抗CD4自身抗体对晚期HIV感染者免疫重建的影响
本研究评估了抗CD4自身抗体在晚期HIV感染者中的纵向影响。在未接受抗逆转录病毒治疗(ART)的晚期HIV感染者中,29%(61/210)检出抗CD4自身抗体;携带该抗体的患者CD4重建速率较慢(5.8 vs 6.6 个/µL/月,P=0.007),第192周CD4计数较低(268 vs 355 个/µL,P=0.037);偶然使用的免疫抑制治疗与CD4重建改善相关。
要点
- 晚期HIV感染者中29%(61/210)检出抗CD4自身抗体,女性患病率是男性的4倍(P<.001)。
- 携带抗CD4自身抗体者CD4重建速率较慢(5.8 vs 6.6 个/µL/月,P=0.007),第192周CD4计数较低(268 vs 355 个/µL,P=0.037)。
- 偶然的免疫抑制治疗与CD4重建速率改善(P=0.0019)及第192周CD4计数较高(551 vs 268 个/µL,P=0.019)相关。
核心结论
- 在ART启动时携带抗CD4自身抗体的晚期HIV感染者,4年后CD4重建的速率和程度较慢。
- 偶然的免疫抑制治疗与这些参与者CD4计数增加相关。
研究设计与样本
- 研究纳入未接受ART的晚期HIV感染者(CD4计数≤100个/µL)、CD4计数>200个/µL的HIV感染者、长期不进展者、特发性CD4淋巴细胞减少症患者、自身免疫性淋巴增殖综合征患者及无HIV的健康志愿者。
- 采用液相荧光素酶免疫沉淀系统免疫分析法检测抗CD4自身抗体。
- 在晚期HIV感染者中评估ART启动时抗CD4自身抗体与中位随访192周期间CD4恢复的关联。
主要发现
- 29%(61/210)的未接受ART的晚期HIV感染者检出抗CD4自身抗体,无HIV者未检出。
- 女性HIV感染者抗CD4自身抗体患病率是男性的4倍(P<.001)。
- 携带抗CD4自身抗体的晚期HIV感染者CD4重建速率较慢(5.8 vs 6.6 个/µL/月,P=0.007),第192周CD4计数较低(268 vs 355 个/µL,P=0.037)。
- 偶然的、有临床指征的免疫抑制治疗与CD4重建速率改善(P=0.0019)及第192周CD4计数较高(551 vs 268 个/µL,P=0.019)相关。
局限性
- 原文未报告局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Despite suppressive antiretroviral therapy (ART), 15%-30% of people with human immunodeficiency virus (HIV) experience a limited recovery of CD4 T cells. Although autoantibodies against the CD4 receptor have previously been identified in people with HIV (PWH), little is known about their longitudinal impact on CD4 T-cell reconstitution. METHODS: Anti-CD4 autoantibodies were evaluated by the fluid-phase luciferase immunoprecipitation systems immunoassay in ART-naive people with advanced HIV (CD4 count ≤100 cells/µL), PWH with CD4 count >200 cells/µL, long-term nonprogressors, people with idiopathic CD4 lymphopenia, people with autoimmune lymphoproliferative syndrome, and healthy volunteers without HIV. In the participants with advanced HIV, we assessed the association of anti-CD4 autoantibodies at ART initiation with CD4 recovery over a median follow-up of 192 weeks. RESULTS: Anti-CD4 autoantibodies were identified in 29% (61/210) of ART-naive participants with advanced HIV but were absent in people without HIV. Female PWH showed a 4-fold higher prevalence (P < .001) of anti-CD4 autoantibodies compared to males. After ART initiation, people with advanced HIV with anti-CD4 autoantibodies exhibited an overall slower rate of CD4 reconstitution (5.8 vs 6.6 cells/µL/month, P = .007) and lower week 192 CD4 count (268 vs 355 cells/µL, P = .037). Incidental, clinically indicated immunosuppressive therapy in these participants was associated with an improved rate of CD4 reconstitution (P = .0019) and higher week 192 CD4 count (551 vs 268 cells/µL, P = .019). CONCLUSIONS: People with advanced HIV harboring anti-CD4 autoantibodies at ART initiation demonstrated a slower rate and extent of CD4 reconstitution after 4 years. Incidental immunosuppressive therapy was associated with increased CD4 counts in these participants.
引用
- Epling BP, Lisco A, Manion M, et al. Impact of Anti-CD4 Autoantibodies on Immune Reconstitution in People With Advanced HIV. Clin Infect Dis. 2025. PMID: 39692471. doi:10.1093/cid/ciae562
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。